Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
-Contineum is focused on leading the Neuroscience, Inflammation and Immunology (NI&I) field- -Successful completion of Initial Public Offering with strong syndicate of existing and new investors- SAN DIEGO, May 16,…